Literature DB >> 4000270

A role for branchpoints in splicing in vivo.

G Rautmann, R Breathnach.   

Abstract

The nucleotides immediately surrounding intron/exon junctions of genes transcribed by RNA polymerase B can be derived from 'consensus' sequences for donor and acceptor splice sites by only a few base changes. Studies in vivo have underlined the importance of these junction nucleotides for splicing. In higher eukaryotes, no evidence has been found for specific internal intron sequences involved in splicing. However, the recent discovery that, in vitro, introns are excised in a lariat form where the 5' end of the intron is joined via a 2'-5'-phosphodiester linkage to an A residue (branchpoint acceptor) close to the 3' end of the intron, suggests that internal intron sequences may nonetheless be important for splicing. Indeed, in yeast nuclear genes, the internal sequence 5'-TACTAAC-3' (or close homologue) is essential for splicing in vivo. A proposed consensus sequence for branchpoints in mammalian introns is 5'-CT(A/G)A(C/T)-3'. This sequence resembles the essential yeast internal sequence. Are branchpoints involved in the splicing of introns of higher eukaryotes in vivo? We show here that a branchpoint sequence from a human globin gene (5'-CTGACTCTCTCTG-3') greatly enhances the efficiency of splicing of a 'synthetic' intron in HeLa cells. A mutated branchpoint sequence, 5'-CTCCTCTCTCTG-3', in which the branchpoint acceptor nucleotide A has been deleted and the neighbouring purine G mutated to a C, does not exhibit this enhancing capability. We conclude that branchpoints have an important function in the splicing process in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000270     DOI: 10.1038/315430a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

Review 1.  trans and cis splicing in trypanosomatids: mechanism, factors, and regulation.

Authors:  Xue-hai Liang; Asaf Haritan; Shai Uliel; Shulamit Michaeli
Journal:  Eukaryot Cell       Date:  2003-10

2.  In vivo splicing of the premRNAs from early region 3 of adenovirus-2: the products of cleavage at the 5' splice site of the common intron.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

3.  Exon definition may facilitate splice site selection in RNAs with multiple exons.

Authors:  B L Robberson; G J Cote; S M Berget
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

4.  The length but not the sequence of the polyoma virus late leader exon is important for both late RNA splicing and stability.

Authors:  G R Adami; G G Carmichael
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

5.  Specific regions of the intervening sequences of beta-globin RNA are resistant to nuclease in 50S heterogeneous nuclear RNA-protein complexes.

Authors:  J R Patton; C B Chae
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Possible evolution of splice-junction signals in eukaryotic genes from stop codons.

Authors:  P Senapathy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Role of the branch site/3'-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5'- and 3'-splice site co-operation.

Authors:  P J Ulfendahl; J P Kreivi; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

8.  Multiple interactions between the splicing substrate and small nuclear ribonucleoproteins in spliceosomes.

Authors:  B Chabot; J A Steitz
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

9.  In vitro processing of a plant pre-mRNA in a HeLa cell nuclear extract.

Authors:  K Hartmuth; A Barta
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

10.  UACUAAC is the preferred branch site for mammalian mRNA splicing.

Authors:  Y A Zhuang; A M Goldstein; A M Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.